MEDICINOVA INC

MNOV

MEDICINOVA INC

MNOV

Insider Sentiment (TTM):

Last Purchase:2020-03-13Last Sale:2022-11-28Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:5,379,536Shares Outstanding:49,221,246Institutional Ownership Pct.:10.93%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	25	27	31	33	34	37	40	42	44	47	51	52
Accounts Receivable Net Current	0	0	-	0	0	-	-	-	-	-	-	1
Prepaid Expense And Other Assets Current	1	1	0	0	1	1	1	1	1	1	0	0
Assets Current	26	28	31	33	35	38	41	43	46	48	51	53
Goodwill	10	10	10	10	10	10	10	10	10	10	10	10
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	1	1	1
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	40	43	46	48	50	52	56	58	60	63	66	68
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	1	1	1	1	1	1	1	1	1
Contract With Customer Liability Current	0	0	0	1	-	-	-	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	3	3	4	3	3	2	3	3	2	3	3	3
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	3	3	4	4	3	3	3	3	3	3	4	3
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	481	481	480	480	480	480	479	479	479	478	478	478
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-444	-441	-439	-436	-433	-430	-427	-424	-421	-418	-416	-414
Stockholders Equity	37	39	42	44	47	50	53	55	57	60	62	65
Liabilities And Stockholders Equity	40	43	46	48	50	52	56	58	60	63	66	68
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	49	49	49	49	49	49	49	49	49	49	49	49
Shares Outstanding	49	49	49	49	49	49	49	49	49	49	49	49

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-6.43%	2.14%	-4.29%	-	-	-	-	-	-	-	-	-
2025	-3.42%	-14.38%	-2.05%	-0.77%	-1.54%	27.69%	-0.64%	-15.29%	9.55%	2.13%	-0.71%	-3.55%
2024	-6.85%	-1.37%	-10.27%	30.43%	66.09%	44.35%	17.00%	6.50%	-1.00%	-21.32%	-29.95%	-25.38%
2023	-	-	-	-	-	-	-0.56%	-16.20%	-17.88%	3.70%	10.37%	-2.96%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.75	9.09	8.16	9.86	13.26	17.66	13.88	16.66	18.24	19.07	15.61	18.92
Quick Ratio	8.58	8.91	8.11	9.76	12.99	17.14	13.64	16.28	17.78	18.78	15.55	18.74
Working Capital	22.96M	25.05M	27.19M	29.59M	32.48M	35.55M	38.12M	40.67M	43.01M	45.35M	47.90M	50.19M
Leverage & Debt
Debt to Equity	0.08	0.08	0.10	0.08	0.06	0.05	0.06	0.06	0.05	0.05	0.06	0.05
Debt Ratio	0.08	0.08	0.09	0.08	0.06	0.05	0.06	0.05	0.05	0.05	0.06	0.05
Efficiency & Turnover
Asset Turnover TTM	0.02	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.01	0.01
Days Sales Outstanding TTM	-	149.94	-	-	365.00	-	-	-	-	-	-	365.00
Receivables Turnover TTM	-	2.43	-	-	1.00	-	-	-	-	-	-	1.00
Per Share Metrics
Diluted EPS TTM	-0.22	-0.24	-0.24	-0.24	-0.24	-0.23	-0.23	-0.21	-0.17	-0.17	-0.17	-0.19
Free Cash Flow Per Share TTM	-0.19	-0.19	-0.20	-0.20	-0.21	-0.22	-0.22	-0.19	-0.17	-0.17	-0.15	-0.22
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-1,287.41%	-2,164.84%	-3,242.47%	-5,185.49%	-9,883.02%	-	-	-	-981.95%	-1,007.30%	-990.03%	-1,064.14%
Net Profit Margin TTM	-1,168.20%	-1,964.35%	-2,928.78%	-4,656.65%	-8,775.80%	-	-	-	-816.49%	-840.85%	-857.15%	-951.39%
Growth Metrics
Net Revenue Growth (1Y)	583.87%	-	-	-	-86.54%	-100.00%	-100.00%	-100.00%	-	-	-	-
Net Income Growth (1Y)	-8.97%	5.03%	8.58%	16.67%	44.67%	32.71%	28.91%	8.20%	-34.38%	-38.17%	-39.08%	-27.65%
EPS Growth (1Y)	-9.29%	4.65%	8.55%	16.67%	44.67%	32.71%	28.91%	8.20%	-34.38%	-38.17%	-39.08%	-27.65%
Valuation Metrics
P/E TTM	-6.04	-5.75	-5.36	-5.19	-5.44	-6.42	-9.32	-10.01	-8.65	-8.46	-8.58	-10.77
P/B TTM	1.74	1.71	1.55	1.42	1.37	1.43	1.96	1.87	1.23	1.19	1.18	1.59
P/S TTM	70.58	113.02	156.89	241.51	477.35	-	-	-	70.63	71.12	73.57	102.51
Market Cap	64.97M	67.43M	64.27M	62.29M	64.25M	71.61M	103.00M	103.00M	70.63M	71.12M	73.57M	102.51M
Enterprise Value	39.56M	40.10M	33.47M	29.73M	29.99M	35.04M	62.64M	60.72M	26.29M	23.98M	22.57M	51.00M
Calculated Values
Free Cash Flow TTM	-9.12M	-9.51M	-9.81M	-9.73M	-10.05M	-10.56M	-10.64M	-9.21M	-8.55M	-8.14M	-7.45M	-10.96M
Net Debt	-25.42M	-27.33M	-30.81M	-32.56M	-34.26M	-36.57M	-40.36M	-42.28M	-44.34M	-47.14M	-51.00M	-51.51M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-11-28Sale

Owner: Nagao, Hideki

Title: -

Shares: 6,754

Price/Share: $2.25

Value: $15,196.50

Shares Owned: -

Relationship: Director

Ownership: Direct

2022-11-22Sale

Owner: Nagao, Hideki

Title: -

Shares: 218

Price/Share: $2.13

Value: $464.34

Shares Owned: 6,754

Relationship: Director

Ownership: Direct

2022-11-17Sale

Owner: Nagao, Hideki

Title: -

Shares: 309

Price/Share: $2.18

Value: $673.62

Shares Owned: 12,337

Relationship: Director

Ownership: Direct

2021-03-11Sale

Owner: Nagao, Hideki

Title: -

Shares: 2,354

Price/Share: $7.40

Value: $17,419.60

Shares Owned: 12,646

Relationship: Director

Ownership: Direct

2020-09-15Sale

Owner: Nagao, Hideki

Title: -

Shares: 1,000

Price/Share: $5.78

Value: $5,780.00

Shares Owned: 15,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-11-28	Nagao, Hideki	Director	-	Direct	Sale	6,754	2.25	$15,196.50	0	4
2022-11-22	Nagao, Hideki	Director	-	Direct	Sale	218	2.13	$464.34	6,754	4
2022-11-17	Nagao, Hideki	Director	-	Direct	Sale	309	2.18	$673.62	12,337	4
2021-03-11	Nagao, Hideki	Director	-	Direct	Sale	2,354	7.40	$17,419.60	12,646	4
2020-09-15	Nagao, Hideki	Director	-	Direct	Sale	1,000	5.78	$5,780.00	15,000	4
2020-03-13	Matsuda, Kazuko	Director,Officer	Chief Medical Officer	Direct	Purchase	2,000	3.62	$7,240.00	111,746	4/A
2020-03-12	Iwaki, Yuichi	Director,Officer	President and CEO	Direct	Purchase	20,000	3.10	$62,000.00	780,683	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

10.93%

Inst. Shares: 5,379,536

Shares Outstanding: 49,221,246

2025-12-31

10.71%

Inst. Shares: 5,255,619

Shares Outstanding: 49,063,438

2025-09-30

10.45%

Inst. Shares: 5,123,770

Shares Outstanding: 49,046,246

2025-06-30

10.31%

Inst. Shares: 5,058,636

Shares Outstanding: 49,046,246

2025-03-31

10.45%

Inst. Shares: 5,124,075

Shares Outstanding: 49,046,246

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	5,379,536	49,221,246	10.93%
2025-12-31	5,255,619	49,063,438	10.71%
2025-09-30	5,123,770	49,046,246	10.45%
2025-06-30	5,058,636	49,046,246	10.31%
2025-03-31	5,124,075	49,046,246	10.45%
2024-12-31	5,131,227	49,046,246	10.46%
2024-09-30	4,821,851	49,046,246	9.83%
2024-06-30	4,681,455	49,046,246	9.54%
2024-03-31	4,338,841	49,046,246	8.85%
2023-12-31	4,525,885	49,046,246	9.23%
2023-09-30	4,606,084	49,046,246	9.39%
2023-06-30	4,957,488	49,046,246	10.11%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MEDICINOVA INC (MNOV) — SEC Financial Statements & Analysis

MEDICINOVA INC (MNOV) is a pharmaceutical preparations company, incorporated in DE. MEDICINOVA INC trades on Nasdaq as: MNOV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MEDICINOVA INC reported a 583.87% year-over-year revenue growth, a Debt-to-Equity ratio of 0.08x, a Price-to-Sales (P/S) ratio of 70.58x (TTM), a Price-to-Book (P/B) ratio of 1.74x (TTM), at a market cap of $64.97M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 583.87%
Debt To Equity: 0.08x
P/S TTM: 70.58x
P/B TTM: 1.74x
Market Cap: $64.97M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MEDICINOVA INC in?

MEDICINOVA INC (MNOV) operates in the Pharmaceutical Preparations industry.

What is MNOV's market cap?

MEDICINOVA INC (MNOV) has a market capitalization of $64.97M as of 2026-06-30.

What exchange does MNOV trade on?

MEDICINOVA INC (MNOV) trades on the Nasdaq.

Where is MEDICINOVA INC incorporated?

MEDICINOVA INC is incorporated in DE.

MEDICINOVA INC

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

MEDICINOVA INC (MNOV) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

MEDICINOVA INC (MNOV) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.